Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Iolanda, Speranza"'
Autor:
Mattia Alberto Di Civita, Andrea Torchia, Daniele Santini, Daniele Marinelli, Virginia Magro, Marianna Cerro, Laura Pappalardo, Giulia Maltese, Fiorenza Santamaria, Luca Zacco, Dorelsa Buccilli, Ailin Dehghanpour, Iolanda Speranza, Alessandro Sciarra, Valeria Panebianco, Michela Roberto
Publikováno v:
Current Oncology, Vol 31, Iss 8, Pp 4713-4727 (2024)
Introduction. Platinum-based chemotherapy represents the standard of care (SoC) for the first-line treatment of advanced urothelial carcinoma (mUC). The benefit of adding immune checkpoint inhibitors (ICIs) to platinum-based chemotherapy was recently
Externí odkaz:
https://doaj.org/article/9b78cad03c694aaaa786dc77973e882a
Autor:
Carmen Cantisani, Federica Trovato, Luca Gargano, Antonio Di Guardo, Alexandru Bâja Vasile, Emanuele Rovaldi, Giulia Azzella, Iolanda Speranza, Giuseppe Soda, Michela Roberto, Tiziana Lettera, Giovanni Pellacani
Publikováno v:
JEADV Clinical Practice, Vol 3, Iss 2, Pp 687-692 (2024)
Abstract Breast cancer represents the most common malignancy in women worldwide. In most cases, metastasis is the leading cause of mortality. Early diagnosis is still challenging despite standardised, government‐led screening programs, but is cruci
Externí odkaz:
https://doaj.org/article/bb4c8b238e0746239cac7ec2f4633d38
Autor:
Francesca Sofia Di Lisa, Eriseld Krasniqi, Laura Pizzuti, Maddalena Barba, Katia Cannita, Ugo De Giorgi, Fulvio Borella, Jennifer Foglietta, Anna Cariello, Antonella Ferro, Elisa Picardo, Marco Mitidieri, Valentina Sini, Simonetta Stani, Giuseppe Tonini, Daniele Santini, Nicla La Verde, Anna Rita Gambaro, Antonino Grassadonia, Nicola Tinari, Ornella Garrone, Giuseppina Sarobba, Lorenzo Livi, Icro Meattini, Giuliana D’Auria, Matteo Vergati, Teresa Gamucci, Mirco Pistelli, Rossana Berardi, Emanuela Risi, Francesco Giotta, Vito Lorusso, Lucia Rinaldi, Salvatore Artale, Marina Elena Cazzaniga, Fable Zustovich, Federico Cappuzzo, Lorenza Landi, Rosalba Torrisi, Simone Scagnoli, Andrea Botticelli, Andrea Michelotti, Beatrice Fratini, Rosa Saltarelli, Ida Paris, Margherita Muratore, Alessandra Cassano, Lorenzo Gianni, Valeria Gaspari, Enzo Maria Veltri, Federica Zoratto, Elena Fiorio, Maria Agnese Fabbri, Marco Mazzotta, Enzo Maria Ruggeri, Rebecca Pedersini, Maria Rosaria Valerio, Lorena Filomeno, Mauro Minelli, Paola Scavina, Mimma Raffaele, Antonio Astone, Roy De Vita, Marcello Pozzi, Ferdinando Riccardi, Filippo Greco, Luca Moscetti, Monica Giordano, Marcello Maugeri-Saccà, Alessandro Zennaro, Claudio Botti, Fabio Pelle, Sonia Cappelli, Flavia Cavicchi, Enrico Vizza, Giuseppe Sanguineti, Federica Tomao, Enrico Cortesi, Paolo Marchetti, Silverio Tomao, Iolanda Speranza, Isabella Sperduti, Gennaro Ciliberto, Patrizia Vici
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundIn triple negative breast cancer patients treated with neoadjuvant chemotherapy, residual disease at surgery is the most relevant unfavorable prognostic factor. Current guidelines consider the use of adjuvant capecitabine, based on the resu
Externí odkaz:
https://doaj.org/article/9054ef5212d94639a5488c4656e59bc0
Autor:
Monica Verrico, Michela Roberto, Giacomo Barchiesi, Francesca Sofia Di Lisa, Teresa Arcuri, Luca Vivona, Fernando Fuccillo, Vincenzo Astorino, Dorelsa Buccilli, Giulia Maltese, Mattia Alberto Di Civita, Amedeo Votto, Andrea Ballario, Nertila Cara, Simone de Meo, Vincenzo Bianco, Iolanda Speranza, Andrea Botticelli, Silverio Tomao
Publikováno v:
Journal of Clinical Oncology. 40:e14529-e14529
e14529 Background: PD-L1 is the only biomarker that has been accepted to identify patients who could potentially benefit from immune checkpoint inhibitors (ICIs) administration, but also PD-L1 negative tumors respond to immunotherapy. However, other
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec7b0eeacab6e10512e155afc415b84a
https://doi.org/10.1200/jco.2022.40.16_suppl.e14529
https://doi.org/10.1200/jco.2022.40.16_suppl.e14529
Autor:
Giacomo Perugia, Emanuele Corongiu, Sara Elena Rebuzzi, Giuseppe Borgoni, Vincenzo Bianco, Arsela Prelaj, Fabio Massimo Magliocca, Iolanda Speranza, M. Liberti
Publikováno v:
The American Journal of Case Reports
Patient: Male, 71 Final Diagnosis: Neuroendocrine cancer bladder Symptoms: Dysuria • haematuria Medication: — Clinical Procedure: Transurethral resection of the bladder tumor Specialty: Oncology Objective: Rare disease Background: Small cell carc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10b5afe127c00a68f4007c247946e350
https://doi.org/10.12659/ajcr.896989
https://doi.org/10.12659/ajcr.896989
Autor:
Rita, De Sanctis, Silvia, Quadrini, Flavia, Longo, Vittoria, Lapadula, Rossella, Restuccia, Ester, Del Signore, Lucilla, De Filippis, Luciano, Stumbo, Bruno, Gori, Vincenzo, Bianco, Iolanda, Speranza, Maria Luisa, Basile, Marisa, Di Seri
Aims and background Capecitabine is the reference treatment for anthracycline-and/or taxane-pretreated metastatic breast cancer (MBC). This study examined its efficacy, tolerability and impact on the quality of life of elderly patients with MBC. Mate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d66ec58c1d09ede2d8233eee2dfd3c27
http://hdl.handle.net/11573/872710
http://hdl.handle.net/11573/872710
Autor:
Vincenzo Bianco, C. G. Messina, Michelangelo Russillo, L. De Filippis, M. Restuccia, E. Proietti, M. Di Seri, Linda Cerbone, Flavia Longo, G. M. L. Basile, Iolanda Speranza, A. Zivi
Publikováno v:
Journal of Clinical Oncology. 25:1080-1080
1080 Background: X has demonstrated consistently high single-agent activity and good tolerability in pretreated and chemonaive MBC, and extends survival when added to docetaxel. High activity, minimal myelosuppression and no alopecia make X interesti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7709ed000976c143076913caec00ad4
https://doi.org/10.1200/jco.2007.25.18_suppl.1080
https://doi.org/10.1200/jco.2007.25.18_suppl.1080